Audit of glycemic control in patients with type 1 diabetes referred to a pediatric clinic in a specialized center in Kuwait

Affiliations


Abstract

Introduction: Intensive glycemic control reduces the risk of microvascular and macrovascular complications. Furthermore, optimal glycemic control is essential for normal growth and development. Thus, there is a need to monitor and evaluate glycemic control in patients with type 1 diabetes (T1D). Our aim was to audit glycemic control in patients with T1D in a specialized center as per the Society of Pediatric and Adolescent Diabetes (ISPAD) Hemoglobin A1C (HbA1C) target recommendations published in 2014.

Methods: This is a retrospective cross-sectional study reporting on glycemic control (HbA1C) of patients younger than 21 years of age and with T1D treated at Dasman Diabetes Institute (DDI) between January 2013 and December 2015.

Results: A total of 470 patients with T1D (250 males and 220 females) were included. Only 53 (11.3%) patients met the ISPAD target for optimal glycemic control with HbA1C < 7.5% (58 mmol/mol). Older age was positively associated with poor glycemic control (p = 0.001) while Continuous Subcutaneous Insulin Infusion (CSII) therapy was negatively associated with poor glycemic control, adjusted Odds Ratio (OR) 0.33 (95% confidence interval (CI): 0.16-0.66) for CSII and adjusted OR 0.42 (95% CI: 0.27-0.64) for shifting to CSII (p < 0.001).

Conclusion: Achieving optimal glycemic control is a significant challenge for young patients with T1D. Glycemic control goals should be individualized to achieve such goals safely, realistically and with a better quality of life for patients with T1D.

Keywords: Audit; Diabetes; Glycemic control; Kuwait; Type 1 diabetes.


Similar articles

Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain.

Enes P, Martín-Frías M, Álvarez MÁ, Yelmo R, Alonso M, Barrio R.Diabetes Res Clin Pract. 2015 Feb;107(2):300-5. doi: 10.1016/j.diabres.2014.08.033. Epub 2014 Sep 17.PMID: 25595220

Above 40% of Polish children and young adults with type 1 diabetes achieve international HbA1c target - results of a nationwide cross-sectional evaluation of glycemic control: The PolPeDiab HbA1c study.

Szadkowska A, Baranowska-Jaźwiecka A, Michalak A, Jarosz-Chobot P, Myśliwiec M, Głowińska-Olszewska B, Szypowska A, Nazim J, Mazur A, Szalecki M, Skowrońska B, Kucharska-Zubkiewicz A, Beń-Skowronek I, Walczak M, Klupa T, Wolnik B, Zozulińska-Ziółkiewicz D, Młynarski W; PolPeDiab HbA1c Study Group.Pediatr Diabetes. 2021 Nov;22(7):1003-1013. doi: 10.1111/pedi.13250. Epub 2021 Aug 4.PMID: 34351670

A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain.

Beato-Víbora P, Chico-Ballesteros A, Giménez M, Guerrero-Vázquez R, Barrio-Castellanos R, Goñi-Iriarte MJ, Díaz-Soto G, Merino-Torres JF, Moreno-Fernández J, Martínez-Brocca MA; Diabetes Technology Working Group of the Spanish Diabetes Association.Diabetes Res Clin Pract. 2018 Mar;137:56-63. doi: 10.1016/j.diabres.2017.12.009. Epub 2017 Dec 24.PMID: 29278712

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x.PMID: 21323816 Review.

Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.

Vinik A.Clin Ther. 2007;29 Spec No:1236-53.PMID: 18046925 Review.


Cited by

Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.

Almazrouei R, Sharma C, Afandi B, Aldahmani KM, Aburawi EH, Beshyah SA, ElGhazali G, Al Yafei Z, Al-Rifai RH, Alkaabi J.PLoS One. 2022 Sep 22;17(9):e0264545. doi: 10.1371/journal.pone.0264545. eCollection 2022.PMID: 36136973 Free PMC article.


KMEL References